Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination With FOLFIRI for the Treatment of Advanced Solid Tumors

NCT05147350 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT05147350
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147350 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination With FOLFIRI for the Treatment of Advanced Solid Tumors
Lead sponsor
Debiopharm International SA
Phase
Phase 1
Overall status
Terminated
Start date
August 9, 2022
Completion date
February 12, 2025
Enrollment
38 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor